Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases

Withdrawn before enrolling · Phase 1

Conditions studied: Lysosomal Storage Diseases, Inborn Errors of Metabolism

In brief

The purpose of this study is to determine if it is safe to administer unrelated umbilical cord blood to pregnant women in their first trimester of pregnancy with a fetus that has a known diagnosis of certain lysosomal storage diseases. These diseases are known to cause severe and irreversible neurological disability in early infancy and which are lethal in childhood.

Key facts

Study ID
NCT01003912
Run by
Joanne Kurtzberg, MD
People needed
0
Starts
2009-10-01
Expected to finish
2017-03-01
Last updated by the study team
2017-06-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.